Author: GlobeNewswire

Webcast Scheduled for Thursday, April 3 at 4:30 p.m. EasternCHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc.…

– Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four…

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the European Medicines Agency…

CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated 1H…

SHANGHAI, March 26, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating…

Receives Court Approval for First Day Motions to Support Ongoing Business OperationsSAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) — 23andMe…

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million,…

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million,…